In this issue:
Adjuvant chemotherapy
Increased activity of oxali-platin in adjuvant setting
Patterns of care and research
Reappraising endpoints in adjuvant treatment trials
Endoscopic surveillance a debatable practice
Supportive care
Evidence on stenting for colorectal obstructions
Chemotherapy in advanced disease
Sequential single-agent regimen has validity
Staged single-agent treatment approach explored
FOLFOXIRI offers advantages over FOLFIRI
CR status and survival compared between regimens
Surgery
Pulmonary metastatectomy benefits certain patients
Risk factors for adverse outcome in APR recipients
Please login below to download this issue (PDF)